Latest filing published 05 Feb 2019 for Aclaris Therapeutics, Inc., €7,951.
Insider track record
Stuart Shanler: trading record in brief
This profile gathers the share dealings of Stuart Shanler in Aclaris Therapeutics, Inc. Over a trading history stretching from 18 December 2016 to 1 February 2019, the count stands at 14 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 February 2019, reports an option exercise in Aclaris Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stuart Shanler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,308 shares@ US$6.9622.7% of flowCommon StockSEC:0001209191-19-007488:1
- 3,875 sharesCommon StockSEC:0001209191-19-007488:0
- 1,450 sharesCommon StockSEC:0001209191-18-063803:0
- 412 shares@ US$6.306.5% of flowCommon StockSEC:0001209191-18-063803:1
- 370 shares@ US$7.316.8% of flowCommon StockSEC:0001209191-18-063370:1
- 1,300 sharesCommon StockSEC:0001209191-18-063370:0
- 5,200 sharesCommon StockSEC:0001209191-18-028861:0
- 1,480 shares@ US$18.1034.3% of flowCommon StockSEC:0001209191-18-028861:1
- 1,450 sharesCommon StockSEC:0001209191-17-066817:2
- 1,300 sharesCommon StockSEC:0001209191-17-066817:0
- 395 shares@ US$24.2312.4% of flowCommon StockSEC:0001209191-17-066817:1
- 441 shares@ US$24.1213.8% of flowCommon StockSEC:0001209191-17-066817:3
- 1,450 sharesCommon StockSEC:0001209191-16-156173:0
- 441 shares@ US$31.2520.2% of flowCommon StockSEC:0001209191-16-156173:1
14 of 14 declarations
